Skip to content

Aura Biosciences, Inc. AURA Prepaid & Other Current

Prepaid & Other Current at other companies

Artesian Resources logo
Artesian ResourcesARTNA
-$670K-80.6%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$9M-47.1%
AAR Corp logo
AAR CorpAIR
$1M-84.1%
BDC
BTC Development Corp. BDCI
$46.73K+40.6%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$2.49M+378%
SAC
Safeguard Acquisition SAC
-$7.24K

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpensesOther.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s prepaid & other current?
Aura Biosciences, Inc. (AURA) reported prepaid & other current of -$1.73M in Q1 2026.
How has Aura Biosciences, Inc.'s prepaid & other current changed year-over-year?
Aura Biosciences, Inc.'s prepaid & other current increased by 42.5% year-over-year, from -$3M to -$1.73M.
What does prepaid & other current mean?
Measures the change in cash outflows related to payments made in advance for goods or services that will be consumed in future periods. An increase in this balance indicates a use of cash, while a decrease represents a source of cash as those assets are expensed. Monitoring this metric helps assess the company's working capital management and short-term liquidity requirements.